Both in Pharmaceuticals
Opko Health vs Omeros
Over the past year OPK returned +27.3% and OMER returned +170.1%; their daily moves had a correlation of 0.03.
OPK +27.3% OMER +170.1%Growth of $1, one year, split-adjusted
| Metric | OPK | OMER |
|---|---|---|
| Price | $1.77 | $18.18 |
| Market cap | $1.32B | $1.32B |
| Today | +2.91% | −0.49% |
| 1 month | +21.2% | −1.8% |
| 6 months | +58.0% | +22.6% |
| Year to date | +40.5% | +5.9% |
| 1 year | +26.4% | +153.6% |
| Revenue growth (YoY) | +4.3% | — |
| Gross margin | 48.9% | 97.2% |
| Net margin | −5.1% | 46.4% |
| P/E (TTM) | — | 10.5× |
| Price / sales | 2.2× | 34.3× |
| Net cash | -$46.5M | $58.7M |
| Dividend yield | — | — |
| Volatility (60d) | 57.6% | 76.7% |
| Short % of float | 9.3% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).